Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Osteopathic Medicine, Rowan-Virtua School of Osteopathic Medicine, Stratford, NJ, USA.
Nicotine Tob Res. 2024 Oct 22;26(11):1455-1462. doi: 10.1093/ntr/ntae119.
Health agencies have called for research evaluating e-cigarette (EC) use in supporting prenatal smoking cessation. This study aimed to describe (1) the characteristics of smokers who begin using electronic cigarettes (ECs) during pregnancy, (2) how frequently smokers reduce or eliminate pre- and post-natal combustible cigarette (CC) use, and (3) the risk for neonatal health complications among smokers who initiate ECs during pregnancy.
Pregnant women using CCs exclusively during prepregnancy, who participated in a U.S. surveillance study, were classified by their reported late-pregnancy smoking behavior as CC-exclusive users, EC initiators, or quitters. EC initiators were further subclassified as dual users (used both ECs and CCs) or EC replacers (used ECs exclusively).
Of 29 505 pregnant smokers, 1.5% reported using ECs during the last three pregnancy months. Among them, 29.7% became EC-exclusive users. EC initiators were disproportionately non-Hispanic White. Relative to quitters, EC initiators had lower income, were less likely to be married, have intended pregnancies, receive first-trimester prenatal care, and participate in a federal assistance program. Compared to CC-exclusive users, EC initiators overall, and dual users specifically, were more likely to reduce pre- and post-natal CC usage relative to prepregnancy levels. EC initiators' risk for neonatal health complications fell between quitters and CC-exclusive users, though the differences were not statistically significant.
Although EC initiators reduced CC use more than CC-exclusive users, only 29.7% reported complete CC cessation, and there was insufficient evidence of reduction in neonatal health complications relative to CC-exclusive users. Currently, ECs should not be considered a viable gestational smoking cessation strategy.
Health agencies have identified a critical need for research evaluating the use of e-cigarettes in supporting prenatal smoking cessation. Using the U.S. Pregnancy Risk Assessment Monitoring System surveillance study data, we provide real-world evidence that prenatal e-cigarette initiation as a smoking cessation tool is used infrequently among pregnant CCs smokers. Most using e-cigarettes in the last 3 months of pregnancy also used CCs.
健康机构呼吁开展研究,评估电子烟(EC)在支持孕妇戒烟方面的作用。本研究旨在描述:(1)在怀孕期间开始使用电子烟(EC)的吸烟者的特征;(2)吸烟者减少或消除产前和产后可燃香烟(CC)使用的频率;(3)在怀孕期间开始使用 EC 的吸烟者,新生儿健康并发症的风险。
在一项美国监测研究中,仅在怀孕前使用 CC 的孕妇,根据其报告的妊娠晚期吸烟行为,分为 CC 专用使用者、EC 使用者和戒烟者。EC 使用者进一步细分为双重使用者(同时使用 EC 和 CC)或 EC 替代者(仅使用 EC)。
在 29505 名怀孕吸烟者中,有 1.5%报告在妊娠最后三个月使用 EC。其中,29.7%成为 EC 专用使用者。EC 使用者中,非西班牙裔白人的比例不成比例。与戒烟者相比,EC 使用者的收入较低,结婚、计划怀孕、接受孕早期产前护理和参与联邦援助计划的可能性较小。与 CC 专用使用者相比,EC 使用者总体上,特别是双重使用者,与怀孕前相比,更有可能减少产前和产后 CC 的使用。EC 使用者的新生儿健康并发症风险低于 CC 专用使用者,但差异无统计学意义。
尽管 EC 使用者减少 CC 的使用量高于 CC 专用使用者,但只有 29.7%报告完全停止 CC 使用,且相对于 CC 专用使用者,减少新生儿健康并发症的证据不足。目前,不应将 EC 视为可行的妊娠期戒烟策略。
健康机构已经确定了一项迫切需要的研究需求,即评估电子烟在支持孕妇戒烟方面的作用。使用美国妊娠风险评估监测系统监测研究数据,我们提供了真实世界的证据,表明在怀孕期间开始使用电子烟作为戒烟工具的情况在怀孕的 CC 吸烟者中很少见。大多数在妊娠最后 3 个月使用 EC 的人也使用 CC。